|
Introduction
As skin ages, it loses some of its collagen and fat and so the skin
becomes wrinkled and lined. Dermal fillers, such as Restylane, are
injected into the skin in areas which need to be plumped up and made
firmer. Restylane is also used as a lip enhancement to shape lips.
There are several types of Restylane, which have different particle
sizes and are used to treat different sizes of lines, wrinkles and
folds.
Restylane Touch - is used for very fine lines and is injected just below
the epidermis.
Restylane - for moderate facial wrinkles. Injected in the middle dermis
layers.
Perlane - for deeper folds and wrinkles. Injected into the deeper
dermis.
Which areas can
be treated?
The most common use for dermal fillers is to increase the size and
volume of lips. Other uses are: the glabellar lines between the
eyebrows; the nasolabial lines running from the root of the nose to the
edge of the mouth; lines around the lips and filling out deep acne
scars.
How is the
treatment carried out?
A full and detailed consultation will be undertaken and the treatment
will be discussed to ensure that expectations and results are in line
with each other. Unlike some dermal fillers, Restylane is not derived
from animals and so a test patch is not required. Therefore treatment
can start immediately.
The area will be wiped with an antiseptic and, if required, an
anaesthetic cream can be applied. For lip injections, a local
anaesthetic injection may be given. The course of injections will last
between 15 to 45 minutes, depending on the areas being treated.
How long does it
last?
Restylane is a temporary dermal filler and follow up sessions are
usually needed every 6 to 12 months. As the treatment is temporary, the
patient is always in control - and can change, augment or modify the
treatment at any time.
Are there any
side effects?
Since its introduction in 1996, over 1.5 million Restylane injections
have been performed and serious side effects have been extremely rare.
In the short term, there may be slight bleeding, swelling or redness as
a result of the injections, although most people are able to go straight
back to work after their treatment.
Other types of reactions are very rare, but about 1 in 2,000 treated
patients have experienced localized reactions thought to be of a
hypersensitivity nature. These have usually consisted of swelling at the
implant site, sometimes affecting the surrounding tissues. Redness,
tenderness and, very rarely, acne-like formations have also been
reported. These reactions have either started a few days after injection
or after a delay of two to four weeks, and have generally been described
as mild to moderate and self-limiting with an average duration of two
weeks.
The treatment is not recommended for pregnant or breastfeeding women. |